Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
Sci Rep ; 11(1): 20231, 2021 10 12.
Article in English | MEDLINE | ID: mdl-34642357

ABSTRACT

Increase of the enteric bacteriophages (phage), components of the enteric virome, has been associated with the development of inflammatory bowel diseases. However, little is known about how a given phage contributes to the regulation of intestinal inflammation. In this study, we isolated a new phage associated with Enterococcus gallinarum, named phiEG37k, the level of which was increased in C57BL/6 mice with colitis development. We found that, irrespective of the state of inflammation, over 95% of the E. gallinarum population in the mice contained phiEG37k prophage within their genome and the phiEG37k titers were proportional to that of E. gallinarum in the gut. To explore whether phiEG37k impacts intestinal homeostasis and/or inflammation, we generated mice colonized either with E. gallinarum with or without the prophage phiEG37k. We found that the mice colonized with the bacteria with phiEG37k produced more Mucin 2 (MUC2) that serves to protect the intestinal epithelium, as compared to those colonized with the phage-free bacteria. Consistently, the former mice were less sensitive to experimental colitis than the latter mice. These results suggest that the newly isolated phage has the potential to protect the host by strengthening mucosal integrity. Our study may have clinical implication in further understanding of how bacteriophages contribute to the gut homeostasis and pathogenesis.


Subject(s)
Bacteriophages/classification , Colitis/microbiology , Enterococcus/pathogenicity , Mucin-2/metabolism , Animals , Bacteriophages/genetics , Bacteriophages/isolation & purification , Colitis/immunology , Disease Models, Animal , Enterococcus/virology , Genome, Viral , High-Throughput Nucleotide Sequencing , Intestinal Mucosa/metabolism , Intestinal Mucosa/pathology , Mice , Mice, Inbred C57BL , Phylogeny , Whole Genome Sequencing
2.
Diab Vasc Dis Res ; 17(4): 1479164120945675, 2020.
Article in English | MEDLINE | ID: mdl-32722929

ABSTRACT

Activation of the prostaglandin E2 receptor EP4 alters polarization of adipose tissue macrophages towards the anti-inflammatory M2 phenotype to suppress chronic inflammation. However, the role of EP4 signalling in pancreatic macrophages that affect insulin secretion is unclear. We examined the role of EP4 signalling in islet inflammation in vitro and in vivo. Obese diabetic db/db mice were treated with an EP4-selective agonist or vehicle for 4 weeks. Islet morphology did not significantly differ and glucose-stimulated insulin secretion was increased, whereas the pancreatic M1/M2 ratio was decreased in the EP4 agonist-treated group compared to the vehicle group. Because EP4 activation in MIN6 cells did not affect insulin secretion, we used a MIN6/macrophage co-culture system to evaluate the role of EP4 signalling in islet inflammation and subsequent inhibition of insulin release. Co-culture with M1-polarized macrophages markedly suppressed insulin expression in MIN6 cells; however, modulation of M1 polarization by the EP4 agonist significantly reversed the negative impact of co-cultivation on insulin production. The enhanced expression levels of pro-inflammatory cytokines in co-cultured MIN6 cells were markedly inhibited by EP4 agonist treatment of M1 macrophages. Thus, EP4 activation may suppress islet inflammation and protect ß-cell function by altering inflammatory macrophages in the diabetic pancreas.


Subject(s)
Cell Plasticity , Diabetes Mellitus, Type 2/metabolism , Inflammation/metabolism , Insulin-Secreting Cells/metabolism , Macrophages, Peritoneal/metabolism , Obesity/metabolism , Receptors, Prostaglandin E, EP4 Subtype/metabolism , Animals , Cell Line, Tumor , Coculture Techniques , Cytokines/metabolism , Diabetes Mellitus, Type 2/pathology , Disease Models, Animal , Inflammation/pathology , Inflammation Mediators/metabolism , Insulin/metabolism , Insulin-Secreting Cells/pathology , Macrophage Activation , Macrophages, Peritoneal/pathology , Mice , Obesity/pathology , Phenotype , Secretory Pathway , Signal Transduction
3.
Proc Natl Acad Sci U S A ; 114(38): 10178-10183, 2017 09 19.
Article in English | MEDLINE | ID: mdl-28878025

ABSTRACT

The commensal microbiota within the gastrointestinal tract is essential in maintaining homeostasis. Indeed, dysregulation in the repertoire of microbiota can result in the development of intestinal immune-inflammatory diseases. Further, this immune regulation by gut microbiota is important systemically, impacting health and disease of organ systems beyond the local environment of the gut. What has not been explored is how distant organs might in turn shape the microbiota via microbe-targeted molecules. Here, we provide evidence that surfactant protein D (SP-D) synthesized in the gallbladder and delivered into intestinal lumen binds selectively to species of gut commensal bacteria. SP-D-deficient mice manifest intestinal dysbiosis and show a susceptibility to dextran sulfate sodium-induced colitis. Further, fecal transfer from SP-D-deficient mice to wild-type, germ-free mice conveyed colitis susceptibility. Interestingly, colitis caused a notable increase in Sftpd gene expression in the gallbladder, but not in the lung, via the activity of glucocorticoids produced in the liver. These findings describe a unique mechanism of interorgan regulation of intestinal immune homeostasis by SP-D with potential clinical implications such as cholecystectomy.


Subject(s)
Colitis/metabolism , Gallbladder/metabolism , Gastrointestinal Microbiome , Pulmonary Surfactant-Associated Protein D/metabolism , Animals , Colitis/microbiology , Forkhead Transcription Factors/metabolism , Glucocorticoids/biosynthesis , Homeostasis , Intestinal Mucosa/immunology , Liver/metabolism , Mice, Inbred C57BL , Symbiosis , T-Lymphocytes, Regulatory/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...